Inhibition of Platelet-Derived Growth Factor and Epidermal Growth Factor Receptor Signaling Events after Treatment of Cells with Specific Synthetic Inhibitors of Tyrosine Kinase Phosphorylation

作者: A. Levitzki , G. Mcmahon , A. Gazit , L. J. Huber , J.-M. Tsai

DOI:

关键词:

摘要: The receptor kinase activity associated with the epidermal growth factor (EGF) and platelet-derived (PDGF) plays an important role in ligand-induced signaling events. effect of specific, synthetic chemical inhibitors PDGF- EGF-mediated tyrosine autophosphorylation on were examined NIH 3T3 cells overexpressing PDGF or EGF receptors. Specific inhibition ligand-dependent autophosphorylation, PI3K activation, mitogen-activated protein (MAPK) cyclin E-associated cell proliferation was measured after treatment these inhibitors. A inhibitor exhibited specific inhibitory properties when tested for PDGF-induced MAPK activity, entry into S phase activity. showed selective EGF-induced In both cases, compounds found to be effective as inducers arrest accumulation G1 cycle ligand treatment. However, at high concentrations, observed exhibit some nonspecific effects demonstrated by attenuation progression. This demonstrates that it is critical use lowest concentration such will alter response under investigation, have confidence conclusions derived from are valid. We conclude experimental parameters signify useful end points measure relative selectivity affect receptor-mediated signal transduction.

参考文章(49)
L Claesson-Welsh, Platelet-derived growth factor receptor signals. Journal of Biological Chemistry. ,vol. 269, pp. 32023- 32026 ,(1994) , 10.1016/S0021-9258(18)31591-6
L Claesson-Welsh, K Hansen, J McGlade, K Yokote, C H Heldin, S Mori, T Pawson, Direct interaction between Shc and the platelet-derived growth factor beta-receptor. Journal of Biological Chemistry. ,vol. 269, pp. 15337- 15343 ,(1994) , 10.1016/S0021-9258(17)36611-5
E Peles, R Lamprecht, R Ben-Levy, E Tzahar, Y Yarden, Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation. Journal of Biological Chemistry. ,vol. 267, pp. 12266- 12274 ,(1992) , 10.1016/S0021-9258(19)49834-7
Lars Rönnstrand, Alexander Levitzki, Johannes Waltenberger, Annette Böhmer, Carl-Henrik Heldin, Marina Kovalenko, Aviv Gazit, Frank-D. Böhmer, Charlotte Rorsman, Selective Platelet-derived Growth Factor Receptor Kinase Blockers Reverse sis-Transformation Cancer Research. ,vol. 54, pp. 6106- 6114 ,(1994)
D Coppola, A Ferber, M Miura, C Sell, C D'Ambrosio, R Rubin, R Baserga, A FUNCTIONAL INSULIN-LIKE GROWTH FACTOR I RECEPTOR IS REQUIRED FOR THE MITOGENIC AND TRANSFORMING ACTIVITIES OF THE EPIDERMAL GROWTH FACTOR RECEPTOR Molecular and Cellular Biology. ,vol. 14, pp. 4588- 4595 ,(1994) , 10.1128/MCB.14.7.4588
P Hu, B Margolis, E Y Skolnik, R Lammers, A Ullrich, J Schlessinger, Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Molecular and Cellular Biology. ,vol. 12, pp. 981- 990 ,(1992) , 10.1128/MCB.12.3.981
C. S. Sheela Rani, Fang Wang, Elena Fuior, Alvin Berger, Jie Wu, Thomas W. Sturgill, Dana Beitner-Johnson, Derek LeRoith, Lyuba Varticovski, Sarah Spiegel, Divergence in Signal Transduction Pathways of Platelet-derived Growth Factor (PDGF) and Epidermal Growth Factor (EGF) Receptors Journal of Biological Chemistry. ,vol. 272, pp. 10777- 10783 ,(1997) , 10.1074/JBC.272.16.10777
C. D. Stiles, G. T. Capone, C. D. Scher, H. N. Antoniades, J. J. Van Wyk, W. J. Pledger, Dual control of cell growth by somatomedins and platelet-derived growth factor Proceedings of the National Academy of Sciences of the United States of America. ,vol. 76, pp. 1279- 1283 ,(1979) , 10.1073/PNAS.76.3.1279